Literature DB >> 16947067

Drug-related problems in general practice: results from a development project in Denmark.

Birthe Soendergaard1, Bente Kirkeby, Christine Dinsen, Hanne Herborg, Jakob Kjellberg, Peter Staehr.   

Abstract

OBJECTIVE: The objective of the study is identify and document drug-related problems and other possible quality problems in primary care through a pharmacist-run medication review and screening service. GPs' acceptance and implementation rates of the pharmacist's recommendations are evaluated.
METHOD: A community pharmacist worked 20 h per week for 18 months in a GP practice with three GPs.
RESULTS: The pharmacist completed 40 reviews and identified 103 drug-related problems. GPs had a high rate of acceptance of the pharmacist's suggested interventions (83%), and 77% of the recommendations had been implemented. 765 (12.5%) possible quality problems were identified after screening 6094 medical records. The physicians accepted 86% of the recommendations to initiate low dosage ASA and treatment was implemented for 63% of the patients. 76% of the recommendations to initiate Statin treatment were agreed on and 56% were implemented.
CONCLUSIONS: The pharmacist was able to identify drug-related problems and other possible quality problems with regard to quality assurance of individual patient's drug treatment. The GPs accepted and implemented the pharmacist's recommendations. It was feasible to implement the services and to establish well-functioning co-operation between the pharmacist and the GPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947067     DOI: 10.1007/s11096-006-9008-8

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  6 in total

1.  Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice.

Authors:  A G Zermansky; D R Petty; D K Raynor; N Freemantle; A Vail; C J Lowe
Journal:  BMJ       Date:  2001-12-08

2.  Pharmaceutical care research and education project: pharmacists' interventions.

Authors:  R Kassam; K B Farris; L Burback; C I Volume; C E Cox; A Cave
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 May-Jun

3.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care.

Authors:  J Krska; J A Cromarty; F Arris; D Jamieson; D Hansford; P R Duffus; G Downie; D G Seymour
Journal:  Age Ageing       Date:  2001-05       Impact factor: 10.668

4.  A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.

Authors:  John Sellors; Janusz Kaczorowski; Connie Sellors; Lisa Dolovich; Christel Woodward; Andrew Willan; Ron Goeree; Roxanne Cosby; Kristina Trim; Rolf Sebaldt; Michelle Howard; Linda Hardcastle; Jeff Poston
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

5.  Improving primary care in rural Alabama with a pharmacy initiative.

Authors:  Charles T Taylor; Debbie C Byrd; Kem Krueger
Journal:  Am J Health Syst Pharm       Date:  2003-06-01       Impact factor: 2.637

6.  No magic bullets: a systematic review of 102 trials of interventions to improve professional practice.

Authors:  A D Oxman; M A Thomson; D A Davis; R B Haynes
Journal:  CMAJ       Date:  1995-11-15       Impact factor: 8.262

  6 in total
  11 in total

1.  An expert panel assessment of comprehensive medication reviews for clients of community mental health teams.

Authors:  Natasa Gisev; J Simon Bell; Claire L O'Reilly; Alan Rosen; Timothy F Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-10-15       Impact factor: 4.328

Review 2.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

Review 3.  Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review.

Authors:  Marlies M E Geurts; Jaap Talsma; Jacobus R B J Brouwers; Johan J de Gier
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.

Authors:  Victoria Ibañez-Cuevas; Eduardo Lopez-Briz; M Teresa Guardiola-Chorro
Journal:  Pharm World Sci       Date:  2008-10-19

5.  Junior doctors' communication with hospital pharmacists about prescribing: findings from a qualitative interview study.

Authors:  David Rhys Axon; Rosemary Hwee Mei Lim; Penny J Lewis; Sarena Sandher; Jenna Thondee; Karen Edwards; Rachel L Howard
Journal:  Eur J Hosp Pharm       Date:  2018-02-06

6.  An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).

Authors:  Edwin Tan; Kay Stewart; Rohan A Elliott; Johnson George
Journal:  BMC Health Serv Res       Date:  2012-08-09       Impact factor: 2.655

7.  Age and education as factors associated with medication literacy: a community pharmacy perspective.

Authors:  Javier Plaza-Zamora; Isabel Legaz; Eduardo Osuna; María D Pérez-Cárceles
Journal:  BMC Geriatr       Date:  2020-11-25       Impact factor: 3.921

8.  Drug therapy-related problem management in Nigeria community pharmacy - process evaluation with simulated patient.

Authors:  Showande Johnson Segun; Lawal Sodiq Damilola
Journal:  BMC Health Serv Res       Date:  2022-02-16       Impact factor: 2.655

9.  General practitioners' attitudes and preparedness towards Clinical Decision Support in e-Prescribing (CDS-eP) adoption in the West of Ireland: a cross sectional study.

Authors:  Chee Peng Hor; James M O'Donnell; Andrew W Murphy; Timothy O'Brien; Thomas J B Kropmans
Journal:  BMC Med Inform Decis Mak       Date:  2010-01-12       Impact factor: 2.796

10.  Admissions through the emergency department due to drug-related problems.

Authors:  Yosef H Al-Olah; Khalifa M Al Thiab
Journal:  Ann Saudi Med       Date:  2008 Nov-Dec       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.